Company Filing History:
Years Active: 2020
Title: Lijun Zhou: Innovator in Antibody Technology
Introduction
Lijun Zhou is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies.
Latest Patents
One of his notable patents is titled "Antibodies binding LAG-3 and uses thereof." This invention provides an isolated monoclonal antibody that specifically binds to LAG-3. The patent also includes a nucleic acid molecule encoding the antibody, an expression vector, a host cell, and a method for expressing the antibody. Furthermore, it offers an immunoconjugate, a bispecific molecule, and a pharmaceutical composition comprising the antibody, along with diagnostic and treatment methods utilizing the anti-LAG-3 antibody.
Career Highlights
Lijun Zhou is associated with Nanjing Leads Biolabs Co., Ltd., where he continues to advance his research and development efforts. His work focuses on innovative solutions in the field of immunology and therapeutic applications.
Collaborations
He collaborates with notable colleagues, including Xiaoqiang Kang and Shoupeng Lai, who contribute to his research endeavors.
Conclusion
Lijun Zhou's work in antibody technology exemplifies the innovative spirit of modern biotechnology. His contributions are paving the way for advancements in medical diagnostics and treatments.